OxyContin’s global drive: ‘We’re only just getting started’
OxyContin is a dying business in America.
Prescriptions for OxyContin have fallen nearly 40 percent since 2010, meaning billions of dollars in lost revenue for its Connecticut manufacturer, Purdue Pharma.
So the company’s owners, the Sackler family, adopted a new strategy: Put the painkiller that set off the U.S. opioid crisis into medicine cabinets around the world.
- Health Care